Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population

PHASE3CompletedINTERVENTIONAL

Enrollment

283

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 9, 2022

Study Completion Date

December 9, 2022

Conditions

Hip Fractures

Interventions

DRUG

Tranexamic Acid Injectable Solution

100 cc normal saline mixed with 1g of tranexamic acid in solution

OTHER

Placebo

100 cc normal saline

Trial Locations (1)

Lancaster General Heatlh / Penn Medicine, Lancaster

All Listed Sponsors

lead

Lancaster General Hospital

OTHER

NCT03923959 - Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population | Biotech Hunter | Biotech Hunter